Addressing workplace stress and understaffing: The Nova Scotia approach [0.03%]
应对工作压力和人手不足：Nova Scotia的方法
Andrea Bishop,Beverley Zwicker
Andrea Bishop
Lyme disease chemoprophylaxis prescribing before and after pharmacist prescriptive authority in Nova Scotia [0.03%]
药师开方权限授予前后Nova Scotia的莱姆病化学预防抗生素使用情况
Madison Bell,Tasha Ramsey,Shanna Trenaman et al.
Madison Bell et al.
Background: Lyme disease is a bacterial infection transmitted to humans through bites from infected Ixodes species of ticks. Prophylaxis with a single dose of oral doxycycline following a bite from an infected tick reduce...
The role of Alberta pharmacists working in opioid use disorder and their potential to prescribe buprenorphine-naloxone: A qualitative study [0.03%]
阿省药剂师在阿片类药物使用障碍中的作用及其开具布施诺芬-纳洛酮的潜力：一项定性研究
Caitlin Olatunbosun,Mostafa Moharram,Samantha Gottschalk et al.
Caitlin Olatunbosun et al.
Objective: Opioid toxicity continues to have significant morbidity and mortality in Alberta. Opioid agonist therapy is an effective treatment for opiate use disorder (OUD), with first-line treatment with buprenorphine-nal...
Opportunities and challenges associated with the launch of nirmatrelvir/ritonavir (Paxlovid) in British Columbia during the COVID-19 pandemic: A qualitative study to explore community pharmacists' perspectives [0.03%]
新冠疫情下英属哥伦比亚地区推出帕克斯洛维德片(Nirmatrelvir/Ritonavir)的相关机遇与挑战——定性研究社区药剂师的视角
Karen Dahri,Kimberley Sinclair Formerly MacNeil,Jolanta Piszczek et al.
Karen Dahri et al.
Background: In February 2022, a novel antiviral for the treatment of COVID-19, nirmatrelvir/ritonavir (Paxlovid), was approved by Health Canada and made available to patients in British Columbia (BC). BC community pharmac...
Identifying pseudo-resistant hypertension and optimizing diuretic therapy for confirmed resistant cases in primary care [0.03%]
在初级保健中识别假性难治性高血压和优化确诊难治性病例的利尿剂治疗
Joey Champigny,Jeff Nagge
Joey Champigny
Background: Approximately 10% of individuals with hypertension are expected to have resistant hypertension (RH). Many have pseudo-resistant hypertension (p-RH) due to a variety of factors. To date, the prevalence of p-RH ...
Two-Spirit Peoples' experiences accessing and receiving care from community pharmacies [0.03%]
二灵人在社区药房获取和接受护理的经历
Marissa Pirlot,Jaris Swidrovich
Marissa Pirlot
Background: Two-Spirit Peoples face unique challenges in accessing and receiving health care in Canada due to health services, including community pharmacy services, being built on hetero- and cis-normative models that im...
Informing community pharmacists on COPD case-finding methods: A scoping review [0.03%]
关于COPD病例发现方法的社区药剂师调查研究的范畴审查
Omowumi Idowu,Meghan Sebastianski,Janice Y Kung et al.
Omowumi Idowu et al.
Background: Early detection of chronic obstructive pulmonary disease (COPD) is a strategy to address the increasing human and economic costs of this condition. This study aimed to inform pharmacists' case-finding strategi...
Environmentally sustainable opportunities for health systems: Metered-dose inhaler prescribing, dispensing, use and waste at a tertiary academic centre [0.03%]
特三级学术中心的医疗系统中环境可持续发展的机遇：定量吸入器的处方、分发、使用及废物处理状况
Carolanne Caron,Shellyza Sajwani,Katherine Bateman et al.
Carolanne Caron et al.
Background: The Canadian health sector's carbon footprint is among the highest in the world and is responsible for 4.6% of Canada's total greenhouse gas emissions, a quarter of which is linked to pharmaceuticals, with met...